We read with interest the case report by Shah et al. (2014) hypothesizing that coloboma may be a feature of the foetal valproate syndrome (FVS). We have observed four further individuals who presented with ocular coloboma following exposure to sodium valproate (VPA) in utero and believe that this is a true association.
Patient 1
This child, a female, was initially seen at 7 months of age. She was the second child of unrelated parents. Her mother had epilepsy but both parents were otherwise in good health. She was referred for assessment because of mild delay in gross motor development. During pregnancy her mother took 1000 mg VPA daily and was seizure free. A previous pregnancy on a dose of 500 mg VPA daily had resulted in the birth of a healthy boy. No abnormalities were observed on antenatal scans and our patient was born at term weighing 3.83 kg (50-75th centile). On examination, she had a broad forehead, a broad flat nasal bridge, a slightly short nose with a flattened tip, a thin upper lip, downturned corners of the mouth, which was small with an everted lower lip and a slightly small jaw. Her features were considered to be consistent with VPA embryopathy. She was also observed to have had a left isolated iris and choroidoretinal coloboma; however, her vision seemed unaffected by this. Seen again at 19 months of age, she had begun walking but was delayed in her language development. At this time, she was also referred for endocrine assessment because of obesity (BMI SDS + 5.1). Her height was 86.6 cm (98th centile), weight 17.1 kg (above 99.6th centile) and occiptofrontal circumference (OFC) 49.4 cm (91st centile). No cause was identified for the obesity. Chromosomal analysis has not been undertaken.
Patient 2
This boy was the first child born to an otherwise healthy mother who had epilepsy. His mother took 1600 mg of VPA daily in two divided doses throughout pregnancy. He was born at 42 weeks by assisted delivery, weighing 3.48 kg (25th-50th centile). He was observed at birth to have small ears, a small nose with anteverted nares, a smooth, flat philtrum, a thin upper lip and downturned corners of the mouth, all features consistent with FVS. He also had torticollis, a hypospadias with a hooded prepuce and an inguinal hernia. Ocular examination revealed a coloboma affecting both the iris and the retina of the left eye but not the optic disc, and he was also myopic. Chromosomal examination was normal. At 14 months of age, it was observed that he was quite small. His weight was 9.56 kg (10th centile), height 73 cm (3rd centile) and head circumference 45 cm (below 3rd centile). His gross motor development was at the slower end of the normal range and he began to walk at 18 months. On follow-up at 5 years and 3 months, he had mild to moderate learning difficulties and problems with recurrent otitis media.
Patient 3
This boy was born to a healthy father and a mother who had had epilepsy associated with learning disability since childhood. She was taking 1500 g VPA and 600 mg carbamazepine daily but continued to have weekly seizures throughout pregnancy. During pregnancy, a foetal anomaly scan revealed a congenital heart defect. The child was born at 38 weeks of gestation by Caesarean section and weighed 2.41 kg (< 5th centile). After birth, examination confirmed a large atrial septal defect, which required surgical closure, a cleft palate and hypospadias. He had a medially deviated, dorsiflexed great toe and the remainder of his toes overlapped. Facially, he had classical facial features of FVS with neat eyebrows, a short nose, flat philtrum and a downturned mouth. He was also observed to have hypertelorism and brachycephaly. A coloboma affecting the left eye was observed. Ophthalmological examination revealed that this also involved a significant part of the retina and as a result he had very poor vision in the left eye. The right optic nerve was observed to be smaller than the left and he was born with a blocked tear duct. He failed to thrive after birth and required a gastrostomy because of poor feeding. At 10 months, his OFC was 38 cm and he was able to sit alone; however, his gross motor development was delayed by about 4-5 months. He also had some hearing impairment.
Microarray analysis was normal and no other cause for this pattern of problems apart from FVS could be recognized on genetic review.
Patient 4
This case of a male patient has previously been reported by Mo and Ladusans (1999) . Born at 38 weeks, his mother had been taking 1000 mg valproic acid daily in two 500 mg doses during pregnancy. Intrauterine growth retardation was observed, and the birth was assisted by ventouse extraction. He had distinctive dysmorphic features consistent with FVS: hypertelorism, flat nasal bridge, upslanting palpebral fissures, a short nose with anteverted nares, a long shallow philtrum, a downturned mouth and a thin vermillion border. He was also observed to have a right inguinal hernia, talipes equinovarus, tongue tie and a systolic murmur. Cardiac catheterization revealed that he had an absent right pulmonary artery. Further, he had bilateral iris colobomata and reduced visual acuity in the right eye. At 19 months, he was reported to have developmental delay with generalized hypotonia. His gross motor development was at the level of a 10-12-month-old child and he would bottom shuffle and crawl instead of walking. He had good fine motor skills with a pincer grasp. His speech was delayed. At the age of 2 years his weight was 9.53 kg (below 3rd centile), height 78 cm (below 3rd centile) and OFC 47 cm (below 10th centile). Chromosomal analysis revealed a normal 46, XY karyotype.
A number of ocular abnormalities have been described in FVS. In a review by Komza (2001) , 9% of FVS patients had an ocular abnormality. These included esotropia, nystagmus, tear duct anomalies, microphthalmia, cataract and corneal opacities. In a study by Glover et al. (2002) of 46 patients with foetal anticonvulsant syndrome, 67% had ocular abnormalities, with myopia being especially common. Other abnormalities included strabismus, astigmatism, anisometropia and isolated reports of colour vision deficiency and congenital cataract. As stated by Shah et al. (2014) , coloboma is not commonly reported in patients with FVS but our observation of a further four affected patients leads us to suggest that it is a rare but definite manifestation of FVS. A coloboma is a developmental defect of the eye, which can involve the iris, choroid, retina and optic disc. It is a rare occurrence with an incidence of fewer than 1 in 10 000. Embryologically, in the 22-day embryo, bilateral shallow grooves form outpouchings of the forebrain to produce two optic vesicles. These vesicles then invaginate and a fissure is formed at the inferior pole called the choroid fissure. This fissure carries the hyloid artery, which will become the central artery of the retina. By the seventh week, the lips of the choroid fissure fuse to form an optic cup. Colobomata are formed when this fissure fails to close completely. Coloboma may occur as a part of the spectrum of microphthalmia, and in some cases complete anophthalmia may also be present. Coloboma may have a genetic basis but environmental factors are also known to be implicated in the aetiology. Maternal use of thalidomide during pregnancy, for example, has been reported to be associated with coloboma, as has foetal alcohol syndrome. There has been one report in the literature on exposure in utero to another AED, carbamazepine, in a child with coloboma (Sutcliffe et al., 1988) .
Ocular development is directed under tight molecular control, principally involving the genes PAX6 and PAX2. Mutations in PAX6 can produce varied phenotypes including aniridia, coloboma of the optic nerve, ocular coloboma and optic nerve hypoplasia (OMIM 607108). Using Xenopus spp. and zebrafish embryos, Gurvich et al. (2005) demonstrated that through its action as a histone deacetylase inhibitor, VPA affects the expression of a large number of developmental genes. In the eye specifically, VPA has been found to reduce expression of both PAX6 and PAX2. (Pennati et al., 2001; Balmer et al., 2012) In light of this evidence, we therefore hypothesize that ocular coloboma in patients with FVS could be caused by reduction in PAX gene expression. Although coloboma is not a frequent finding with VPA exposure, our observation of coloboma in 4/150 patients with FVS in our clinic and the report by Shah et al. (2014) suggest that it should be added to the list of possible malformations associated with in-utero VPA exposure. For this reason, and because of the increased risk for other ocular pathologies, ophthalmological examination and review should be undertaken as a part of health surveillance in all children of mothers taking VPA during pregnancy.
